Characteristics of adults and children diagnosed with tuberculosis in Lilongwe, Malawi: Findings from an integrated HIV/TB clinic

Tropical Medicine and International Health

Volumn 17, Issue 9, 2012, Pages 1108-1116

  Feldacker, C ^a,b   Tweya, H ^a,c   Keiser, O ^d   Weigel, R ^e   Kalulu, M ^a   Fenner, L ^d   Egger, M ^d   Manda, E ^a   Mwafilaso, J B ^a   Kamba, C ^f   Phiri, S ^a  

^a LIGHTHOUSE TRUST   (Malawi)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d UNIVERSITY OF BERN   (Switzerland)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^f Lilongwe District Health Office   (Malawi)

Author keywords

ART; HIV; Malawi; Smear positive PTB; TB; TB ART service integration

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; CHILD HEALTH; HEALTH RISK; HEALTH STATUS; HUMAN IMMUNODEFICIENCY VIRUS; QUALITATIVE ANALYSIS; SPATIOTEMPORAL ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATED HEALTH CARE SYSTEM; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MALE; MIXED INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; SCREENING; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT; MALAWI; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUBERCULOSIS; YOUNG ADULT;

LILONGWE; MALAWI;

EID: 84865569791     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.03041.x     Document Type: Article

References (41)

1. Abdool Karim SS, Naidoo K, Grobler A et al. (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. New England Journal of Medicine 362, 697-706.
2. Boeree MJ, Harries AD, Godschalk P et al. (2000) Gender differences in relation to sputum submission and smear-positive pulmonary tuberculosis in Malawi Notes from the Field. The International Journal of Tuberculosis and Lung Disease 4, 882-884.
3. Chimzizi R & Harries A (2007) Joint tuberculosis/HIV services in Malawi: progress, challenges and the way forward. Bulletin of the World Health Organization 85, 385-386.
4. Chimzizi R, Gausi F, Bwanali A et al. (2004) Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi. The International Journal of Tuberculosis and Lung Disease 8, 579-585.
5. Corbett EL, Marston B, Churchyard GJ & De Cock KM (2006) Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367, 926-937.
6. Crampin AC, Mwaungulu JN, Mwaungulu FD et al. (2010) Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS (London, England) 24, 417.
7. Government of Malawi Ministry of Health (2011) Integrated HIV Program Report October - December 2011. HIV/AIDS Unit, Department of Clinical Services, Lilongwe, Malawi.
8. Harries AD (1990) Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 335, 387-390.
9. Harries AD, Parry C, Mbewe LN et al. (1997) The pattern of tuberculosis in Queen Elizabeth Central Hospital, Blantyre, Malawi: 1986-1995. The International Journal of Tuberculosis and Lung Disease 1, 346-351.
10. Harries AD, Hargreaves NJ, Chimzizi R & Salaniponi FM (2002a) Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential. Bulletin of the World Health Organization 80, 464-469.
11. Harries AD, Hargreaves NJ, Graham SM et al. (2002b) Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes. The International Journal of Tuberculosis and Lung Disease 6, 424-431.
12. Harries AD, Libamba E, Schouten EJ et al. (2004a) Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. British Medical Journal 329, 1163-1166.
13. Harries AD, Boxshall M, Phiri S & Kwanjana J (2006) Managing HIV and tuberculosis in sub-Saharan Africa. Lancet 367, 1817-1818.
14. Harries AD, Zachariah R, Jahn A, Schouten EJ & Kamoto K (2009a) Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries. Journal of Acquired Immune Deficiency Syndromes 52, S14-S16.
15. Harries AD, Zachariah R & Lawn SD (2009b) Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa [State of the art series. Tuberculosis. Edited by ID Rusen. Number 3 in the series]. The International Journal of Tuberculosis and Lung Disease 13, 6-16.
16. Harries AD, Zachariah R, Corbett EL et al. (2010) The HIV-associated tuberculosis epidemic: when will we act? The Lancet 375, 1906-1919.
17. Khan FA, Minion J, Pai M et al. (2010) Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clinical Infectious Diseases 50, 1288-1299.
18. Kiwanuka J, Graham SM, Coulter JBS et al. (2001) Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Annals of Tropical Paediatrics: International Child Health 21, 5-14.
19. Lawn SD & Wood R (2011) Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. Journal of Infectious Diseases 204(Suppl 4), S1159-S1167.
20. Lawn SD, Myer L, Bekker LG & Wood R (2006) Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. Aids 20, 1605.
21. Lawn SD, Wilkinson RJ, Lipman MCI & Wood R (2008) Immune reconstitution and" unmasking" of tuberculosis during antiretroviral therapy. American Journal of Respiratory and Critical Care Medicine 177, 680.
22. Lawn SD, Campbell L, Kaplan R et al. (2011a) Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township. BMC Infectious Diseases 11, 258.
23. Lawn SD, Fraenzel A, Kranzer K et al. (2011b) Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. South African Medical Journal 101, 258-262.
24. Libamba E, Makombe S, Harries AD et al. (2005) Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes - the case of Malawi. International Journal of Tuberculosis and Lung Disease 9, 1062-1071.
25. Libamba E, Makombe S, Mhango E et al. (2006) Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bulletin of the World Health Organization 84, 320-326.
26. Malawi Ministry of Health (2007) Malawi National Tuberculosis Control Programme Manual MoH, Lilongwe.
27. Ministry of Health Malawi (2008) Treatment of AIDS: Guidelines for the Use of Antiretroviral Therapy in Malawi, 3rd edn, viewed 16 April 2012. http://www.hivunitmohmw.org/Main/AntiretroviralTherapy.
28. Ministry of Health and Population Malawi (2011) ART in the Public Sector in Malawi, Results up to 1st June 2011. Ministry of Health and Population, Malawi.
29. Panjabi R, Comstock GW & Golub JE (2007) Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk [Review Article]. The International Journal of Tuberculosis and Lung Disease 11, 828-837.
30. Phiri S, Khan PY, Grant AD et al. (2011) Integrated tuberculosis and HIV care in a resource limited setting: experience from the Martin Preuss centre, Malawi. Tropical Medicine & International Health 16, 1397-1403.
31. Poerksen G, Kazembe PN & Graham SM (2008) Challenges of Childhood TB/HIV Management in Malawi. Malawi Medical Journal 19, 142-148.
32. Shafer RW, Kim DS, Weiss JP & Quale JM (1991) Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine 70, 384.
33. StataCorp (2005) Stata Statistical Software: Release 9. StataCorp LP, College Station, TX.
34. Tweya H, Kanyerere H, Ben-Smith A et al. (2011) Re-treatment tuberculosis cases categorised as "other": Are they properly managed? PLoS One 6, e28034.
35. Uyei J, Coetzee D, Macinko J & Guttmacher S (2011) Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. The Lancet Infectious Diseases 11, 855-867.
36. WHO (2008) Tuberculosis Detection Rate under DOTS (Percentage), 2011. http://www.who.int/whosis/indicators/compendium/2008/4tdr/en/index.html.
37. WHO (2011) TB Country Profile: Malawi, 2011 https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=MW&outtype=html.
38. World Health Organization (2003) Treatment of Tuberculosis: Guidelines for National Programmes. WHO, Geneva.
39. Zachariah R, Teck R, Ascurra O et al. (2005) Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? International Journal of Tuberculosis and Lung Disease 9, 238-247.
40. Zachariah R, Fitzgerald M, Massaquoi M et al. (2007) Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi? The International Journal of Tuberculosis and Lung Disease 11, 848-853.
41. Zar HJ, Hanslo D, Apolles P, Swingler G & Hussey G (2005) Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. The Lancet 365, 130-134.